The company's technology is at the intersection of Artificial Intelligence & Genomics Big Data. They provide AI to make pharma R&D smarter, faster, and more effective. Their main business are divided into 4 fields, - Information Technology - Bio Technology - Big Data Technology - Healthcare Technology The company is looking for suitable local pharmaceutical firms related to these fields.
The company is a bioinformatics venture firm founded in 2009. It is a research institute funded by the Korea Electronics and Telecommunications Research Institute (ETRI) '2014 supercomputing technology for genetic testing'. They owns Personal Genome Map Technology (PMAP) based on Big data algorithm and it is a genome Big data research institute based on in silico. They manage and analyze genome analysis and massive bio data and genome by with high-performance, high-efficiency supercomputer The company acquired NET (New Excellent Technology) certified by the government with ‘genetic disease screening technology’. The company is currently operated in head office Daejeon Genome Data Integration Center, Seoul KIST R&D Center, Seoul Business Center, Yongin In Silico Medical Research Center, Cheongju Supercom Center.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
The company is interested in: - Local pharmaceutical firms located in France, Italy. - technical cooperation agreement, the company is looking for partners with specific existing COVID 19 technological capacities, in order to better develop the technology. This would increase the technical aspects of the technology and the attractiveness of the technology on the market.
Stage of Development:
Already on the market
Comments Regarding Stage of Development:
Already on the market and plan to cooperate with overseas countries by using current technologies for each partner.
Comments Regarding IPR Status:
The company has obtained many IPRs related to the fields.